BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25616961)

  • 21. Ubiquilin-2 drives NF-κB activity and cytosolic TDP-43 aggregation in neuronal cells.
    Picher-Martel V; Dutta K; Phaneuf D; Sobue G; Julien JP
    Mol Brain; 2015 Oct; 8(1):71. PubMed ID: 26521126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP-43-positive inclusions.
    Honda H; Hamasaki H; Wakamiya T; Koyama S; Suzuki SO; Fujii N; Iwaki T
    Neuropathology; 2015 Feb; 35(1):37-43. PubMed ID: 25338872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquilin 2: a component of the ubiquitin-proteasome system with an emerging role in neurodegeneration.
    Zhang KY; Yang S; Warraich ST; Blair IP
    Int J Biochem Cell Biol; 2014 May; 50():123-6. PubMed ID: 24589709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation.
    Beijer D; Kim HJ; Guo L; O'Donovan K; Mademan I; Deconinck T; Van Schil K; Fare CM; Drake LE; Ford AF; Kochański A; Kabzińska D; Dubuisson N; Van den Bergh P; Voermans NC; Lemmers RJ; van der Maarel SM; Bonner D; Sampson JB; Wheeler MT; Mehrabyan A; Palmer S; De Jonghe P; Shorter J; Taylor JP; Baets J
    JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34291734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2.
    Osaka M; Ito D; Suzuki N
    Biochem Biophys Res Commun; 2016 Apr; 472(2):324-31. PubMed ID: 26944018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lou Gehrig's Disease (ALS): UBQLN2 Mutations Strike Out of Phase.
    Higgins N; Lin B; Monteiro MJ
    Structure; 2019 Jun; 27(6):879-881. PubMed ID: 31167121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UBQLN2 mutations are rare in French and French-Canadian amyotrophic lateral sclerosis.
    Daoud H; Suhail H; Szuto A; Camu W; Salachas F; Meininger V; Bouchard JP; Dupré N; Dion PA; Rouleau GA
    Neurobiol Aging; 2012 Sep; 33(9):2230.e1-2230.e5. PubMed ID: 22560112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function.
    Wu JJ; Cai A; Greenslade JE; Higgins NR; Fan C; Le NTT; Tatman M; Whiteley AM; Prado MA; Dieriks BV; Curtis MA; Shaw CE; Siddique T; Faull RLM; Scotter EL; Finley D; Monteiro MJ
    Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15230-15241. PubMed ID: 32513711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyotrophic lateral sclerosis (ALS) linked mutation in Ubiquilin 2 affects stress granule assembly via TIA-1.
    Peng G; Gu A; Niu H; Chen L; Chen Y; Zhou M; Zhang Y; Liu J; Cai L; Liang D; Liu X; Liu M
    CNS Neurosci Ther; 2022 Jan; 28(1):105-115. PubMed ID: 34750982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical heterogeneity in a family with flail arm syndrome and review of hnRNPA1-related spectrum.
    Han X; Zhan F; Yao Y; Cao L; Liu J; Yao S
    Ann Clin Transl Neurol; 2022 Dec; 9(12):1910-1917. PubMed ID: 36314424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenic mutation of UBQLN2 impairs its interaction with UBXD8 and disrupts endoplasmic reticulum-associated protein degradation.
    Xia Y; Yan LH; Huang B; Liu M; Liu X; Huang C
    J Neurochem; 2014 Apr; 129(1):99-106. PubMed ID: 24215460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia.
    Nementzik LR; Thumbadoo KM; Murray HC; Gordon D; Yang S; Blair IP; Turner C; Faull RLM; Curtis MA; McLean C; Nicholson GA; Swanson MEV; Scotter EL
    Brain Pathol; 2024 May; 34(3):e13230. PubMed ID: 38115557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C9ORF72 and UBQLN2 mutations are causes of amyotrophic lateral sclerosis in New Zealand: a genetic and pathologic study using banked human brain tissue.
    Scotter EL; Smyth L; Bailey JAWT; Wong CH; de Majo M; Vance CA; Synek BJ; Turner C; Pereira J; Charleston A; Waldvogel HJ; Curtis MA; Dragunow M; Shaw CE; Smith BN; Faull RLM
    Neurobiol Aging; 2017 Jan; 49():214.e1-214.e5. PubMed ID: 27480424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.
    Deshaies JE; Shkreta L; Moszczynski AJ; Sidibé H; Semmler S; Fouillen A; Bennett ER; Bekenstein U; Destroismaisons L; Toutant J; Delmotte Q; Volkening K; Stabile S; Aulas A; Khalfallah Y; Soreq H; Nanci A; Strong MJ; Chabot B; Vande Velde C
    Brain; 2018 May; 141(5):1320-1333. PubMed ID: 29562314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No Evidence for Pathogenic Role of UBQLN2 Mutations in Sporadic Amyotrophic Lateral Sclerosis in the Mainland Chinese Population.
    Huang X; Shen S; Fan D
    PLoS One; 2017; 12(1):e0170943. PubMed ID: 28125704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm.
    Kim JH; Hahm B; Kim YK; Choi M; Jang SK
    J Mol Biol; 2000 May; 298(3):395-405. PubMed ID: 10772858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wild-type and pathogenic forms of ubiquilin 2 differentially modulate components of the autophagy-lysosome pathways.
    Idera A; Sharkey LM; Kurauchi Y; Kadoyama K; Paulson HL; Katsuki H; Seki T
    J Pharmacol Sci; 2023 Jul; 152(3):182-192. PubMed ID: 37257946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UBQLN2 in familial amyotrophic lateral sclerosis in The Netherlands.
    van Doormaal PT; van Rheenen W; van Blitterswijk M; Schellevis RD; Schelhaas HJ; de Visser M; van der Kooi AJ; Veldink JH; van den Berg LH
    Neurobiol Aging; 2012 Sep; 33(9):2233.e7-2233.e8. PubMed ID: 22676852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UBQLN proteins in health and disease with a focus on UBQLN2 in ALS/FTD.
    Lin BC; Higgins NR; Phung TH; Monteiro MJ
    FEBS J; 2022 Oct; 289(20):6132-6153. PubMed ID: 34273246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new Drosophila model of Ubiquilin knockdown shows the effect of impaired proteostasis on locomotive and learning abilities.
    Jantrapirom S; Lo Piccolo L; Yoshida H; Yamaguchi M
    Exp Cell Res; 2018 Jan; 362(2):461-471. PubMed ID: 29247619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.